Lecia V. Sequist, discusses the adverse event profiles of rociletinib (CO-1686) and osimertinib (AZD9291).
Lecia V. Sequist
Advertisement
Articles by Lecia V. Sequist
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.
Advertisement
Latest Updated Articles
Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLCSeptember 24th 2015
Lecia V. Sequist on Side Effects From Agents for Resistant Lung CancerSeptember 24th 2015
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Lynch Syndrome: Why Upper Endoscopies and Colonoscopy Prep Save My Life
3
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
4
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
5